Albemarle Announces the Sale of Its Teesport, UK Facility to Kemira

BATON ROUGE, Louisiana, August 2, 2010 - Albemarle Corporation (NYSE: ALB), a global developer and manufacturer of
innovative fine chemicals and sustainable clean energy solutions, announced
today that on July 30, 2010, the company sold its Teesport, UK facility to
Kemira Oyj (HSE: KEM). Terms of the agreement were not disclosed.

(LOGO: photos.prnewswire.com/prnh/20050801/ALBEMARLELOGO )

(LOGO: www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO )

"This transaction is another step in Albemarle's previously announced
restructuring efforts, and we're pleased to finalize the sale," said Luke
Kissam, President of Albemarle.

The Teesport facility currently produces emulsifiers and intermediates
for the drilling fluids industry. Albemarle's completion fluids business is
not a part of this sale. The company will continue to produce its
bromine-based completion fluids in Jordan and the U.S. to service the global
oil field market.

About Albemarle

Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a
leading global developer, manufacturer, and marketer of highly-engineered
specialty chemicals for consumer electronics, petroleum refining, utilities,
packaging, construction, automotive/transportation, pharmaceuticals, crop
protection, food-safety and custom chemistry services. The Company is
committed to global sustainability and is advancing its eco-practices and
solutions in its three business segments, Polymer Solutions, Catalysts and
Fine Chemicals. Corporate Responsibility Magazine recently selected Albemarle
to its prestigious "100 Best Corporate Citizens" list for 2010. Albemarle
employs approximately 4,000 people and serves customers in approximately 100
countries. To learn more, visit www.albemarle.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform
Act of 1995: Statements in this press release regarding Albemarle
Corporation's business that are not historical facts are "forward-looking
statements" that involve risks and uncertainties. For a discussion of such
risks and uncertainties, which could cause actual results to differ from
those contained in the forward-looking statements, see "Risk Factors" in the
Company's Annual Report on Form 10-K.

Media: Stephanie Dixon, +1-225-388-7904, Stephanie.Dixon at albemarle.com, or Investor Relations: Sandra Rodriguez, +1-225-388-7654, Sandra.Rodriguez at albemarle.com